Noom Med Without Insurance — 2026 Pricing, Plans, and Verdict

Last reviewed: September 17, 2026 Last updated: September 17, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Noom Med's microdose GLP-1Rx program charges $79 for an introductory period covering a 3-week subscription plus 4 weeks of medication, then $179/month ongoing for a 12-week subscription billing cycle. Over 12 months, that works out to an effective monthly cost of $170.67 (our calculation: $79 + eleven months at $179 = $2,048 total). The price includes both the behavior-change program and medication. Noom Med also offers a Core Med service at $129/month billed quarterly after the first month, but medication is excluded from that track and must be sourced separately—pricing for that medication was not available in the sources reviewed. Product and formulation details for Noom Med's programs require completing their eligibility questionnaire; branded injection and GLP-1Rx Plus pricing were not captured in available sources.

PlexusDx offers microdose GLP-1 at $129/month month-to-month with no introductory rate, no membership fee, and medication included—$1,548 over 12 months. For readers considering standard-dose semaglutide injection, PlexusDx charges $189/month month-to-month, $169/month prepaid over three months, or $149/month prepaid over six months.

At-a-glance comparison

Sources: Noom Med pricing captured Sept. 4, 2026; PlexusDx pricing verified July 17–23, 2026. Noom Med's introductory rate is for the first period; ongoing rate applies thereafter. PlexusDx pricing is month-to-month with no introductory period.

Noom Med pricing structure: introductory vs. ongoing

Noom Med's microdose GLP-1Rx program uses a two-tier pricing model. The first month costs $79 and covers a 3-week subscription plus 4 weeks of medication (captured Sept. 4, 2026). After the introductory period ends, the program bills $179/month on a 12-week subscription cycle. The ongoing rate includes both the behavior-change program and medication.

To understand the true monthly cost, we calculated the effective rate over 12 months: $79 for month one, then $179/month for the remaining eleven months, totals $2,048. Divide that by 12 and the effective monthly cost is $170.67. This calculation assumes the introductory period covers approximately one month of treatment; actual medication supply may vary based on titration schedule.

What's included

The microdose GLP-1Rx subscription includes access to Noom Med's behavior-change program, clinician consultations, and medication. The program emphasizes behavioral support alongside pharmacotherapy. Product and formulation details—including specific GLP-1 compound and route of administration—require completing Noom Med's eligibility questionnaire; those details were not specified in publicly available pricing sources.

Core Med: medication excluded

Noom Med also offers a Core Med service at $129/month, billed quarterly after the first month ($387 per quarter). This service provides the clinical program and behavior-change support but does not include medication. Medication must be obtained separately, and the cost of that medication was not captured in the sources reviewed. If you are considering Core Med, confirm the total out-of-pocket cost—including medication—before committing.

PlexusDx microdose and standard GLP-1 pricing

PlexusDx offers microdose GLP-1 at a flat $129/month with no introductory pricing, no membership fee, and no prepayment requirement. Medication, provider visit, prescription, and shipping are included. Over 12 months, the total is $1,548—$500 less than Noom Med's microdose program over the same period (our calculation).

For readers evaluating standard-dose semaglutide injection, PlexusDx charges:

• Month-to-month: $189/month ($2,268 over 12 months)
• 3-month prepaid: $169/month ($507 per quarter; $2,028 over 12 months, our calculation)
• 6-month prepaid: $149/month ($894 per half-year; $1,788 over 12 months, our calculation)

Tirzepatide injection is also available at $289/month month-to-month, $269/month prepaid over three months, or $249/month prepaid over six months. Every PlexusDx price is the same at every dose; there are no titration surcharges or membership fees.

12-month cost comparison

All figures are our calculations based on pricing captured Sept. 4, 2026 (Noom Med) and July 17–23, 2026 (PlexusDx). Prepaid figures require upfront payment. Noom Med's introductory period is assumed to cover approximately one month; actual supply may vary by titration protocol.

Decision factors

When the introductory rate matters most

Noom Med's $79 first-month rate lowers the barrier to starting treatment. If you are uncertain whether GLP-1 therapy will work for you and want to test it at minimal upfront cost, the introductory rate offers a low-risk entry point. However, the ongoing $179/month rate exceeds both PlexusDx microdose ($129/month) and standard semaglutide injection prepaid options ($149/month over six months). The first-month savings are absorbed by higher refill costs over time.

Behavior-change program vs. medication-focused care

Noom Med integrates a structured behavior-change curriculum with GLP-1 therapy. If you value daily lessons, habit-tracking tools, and coaching alongside medication, that integration may justify the higher cost. PlexusDx focuses on prescription access and medication delivery; clinical support is available through your provider but does not include a structured behavioral program. Readers who prefer a streamlined medication-only model will find PlexusDx more straightforward and more affordable.

Transparency and product clarity

PlexusDx publishes formulation, dose ranges, and compounding-pharmacy partnerships on its product pages before intake. Noom Med requires completing an eligibility questionnaire to see product and formulation details. If you want to compare specific GLP-1 compounds and routes before committing time to an intake, PlexusDx offers more transparency upfront.

Review evidence

Noom Med holds a 4.5-star rating on Trustpilot with 67,000 reviews (profile-wide, not GLP-1-program-specific; captured Sept. 4, 2026; trustpilot.com/review/noom.com). One captured Reddit report described slow titration and perceived lack of efficacy; this is an individual anecdote and may not represent typical outcomes (captured Sept. 4, 2026). PlexusDx holds a 4.3-star rating on Trustpilot, with 79% of reviews at five stars and 83% at four stars or higher (captured Sept. 9, 2026; trustpilot.com/review/plexusdx.com). Both platforms operate at scale; review volume and consistency matter more than a small ratings difference.

Choose Noom Med if…

You want integrated behavior-change support alongside GLP-1 therapy, you value daily lessons and habit coaching, and you are prepared to pay $179/month ongoing after the introductory period. Noom Med's strength is the combination of pharmacotherapy and structured behavioral programming. If that integration is central to your goals, the higher ongoing cost may be worthwhile. Confirm product and formulation details during intake, and verify that the program's titration schedule aligns with your expectations.

Where PlexusDx fits

PlexusDx is the more affordable option for readers prioritizing transparent pricing, lower ongoing cost, and straightforward medication access. At $129/month flat for microdose GLP-1 or $149/month for standard semaglutide injection (six-month prepaid), PlexusDx costs $41–$50 less per month than Noom Med's microdose program after the introductory period (our calculation). There is no membership fee, no introductory period, and no surprise rate jump after month one. Product details—formulation, compounding pharmacy, dose ranges—are published before intake. If you are looking for medication-focused GLP-1 therapy without behavioral curriculum or coaching, PlexusDx delivers a clearer value proposition and lower total cost over 12 months.

Methodology and freshness

This comparison reflects cash-pay pricing only; insurance and employer coverage are not addressed. Noom Med pricing was captured Sept. 4, 2026, from publicly accessible program descriptions and pricing pages. PlexusDx pricing was verified July 17–23, 2026. The 12-month cost calculations and effective monthly rates are our calculations based on the captured monthly rates and introductory offers. Noom Med's introductory period is assumed to cover approximately one month of treatment; actual medication supply may vary by individual titration protocol. Branded injection and GLP-1Rx Plus pricing for Noom Med were not available in the sources reviewed. Core Med medication costs were not captured. Product and formulation details for Noom Med programs require completing their eligibility questionnaire. Review ratings were captured Sept. 4, 2026 (Noom Med) and Sept. 9, 2026 (PlexusDx) from Trustpilot; Reddit discussion was captured Sept. 4, 2026. All prices and program details should be confirmed at checkout; telemedicine programs may change pricing, inclusions, or eligibility criteria without notice.

Frequently Asked Questions

Does Noom Med accept insurance for GLP-1 medications?

This article addresses cash-pay pricing only. Noom Med may offer insurance billing for certain programs or medications, but those details were not captured in the sources reviewed. Contact Noom Med directly or check during intake to confirm whether your insurance is accepted and whether your plan covers GLP-1 medications prescribed for weight management.

What is the difference between Noom Med's microdose program and Core Med?

The microdose GLP-1Rx program includes both the behavior-change subscription and medication for $79 introductory and $179/month ongoing. Core Med provides the clinical program and coaching for $129/month billed quarterly but excludes medication; you must source medication separately. If you choose Core Med, confirm the total out-of-pocket cost including medication before enrolling.

Why does Noom Med's effective monthly cost differ from the ongoing rate?

The effective monthly cost averages the $79 introductory rate and the $179/month ongoing rate over 12 months, resulting in $170.67/month (our calculation: $79 + $179 × 11 = $2,048 total; $2,048 ÷ 12 = $170.67). This reflects the true per-month cost if you remain on the program for a full year, accounting for the lower first-month price and higher refill rate.

Can I see what medication Noom Med prescribes before I start intake?

Product and formulation details for Noom Med's GLP-1 programs require completing their eligibility questionnaire. Publicly available sources do not specify the GLP-1 compound, dose ranges, or route of administration. If you want to compare specific formulations before committing time to intake, confirm those details with Noom Med support or choose a provider that publishes product information upfront.

Is microdose GLP-1 as effective as standard-dose GLP-1?

Microdose protocols use lower starting doses and slower titration than standard protocols. Some patients tolerate microdosing better and experience fewer side effects; others may see slower weight loss or require eventual transition to standard dosing. Efficacy depends on individual response, adherence, and whether the microdose is part of a maintenance phase or initial treatment. A licensed clinician can help determine which approach fits your medical history and goals. Neither microdose nor standard-dose outcomes are guaranteed.

Sources

• Noom Med pricing and program details captured Sept. 4, 2026
• PlexusDx pricing verified July 17–23, 2026
• Trustpilot review ratings for Noom (4.5 stars, 67K reviews; trustpilot.com/review/noom.com) captured Sept. 4, 2026
• Trustpilot review ratings for PlexusDx (4.3 stars; trustpilot.com/review/plexusdx.com) captured Sept. 9, 2026
• Reddit discussion captured Sept. 4, 2026

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.